Bharat Biotech, WHO pre-submission meeting on June 23: WHO

Credit: IndiaTimes- Published on June 17, 2021
Hyderabad-based Bharat Biotech's pre-submission meeting has been scheduled on June 23 for evaluation of the World Health Organisation (WHO)'s Emergency Use Listing (EUL) of its indigenous COVID-19 vaccine Covaxin.

You are here


๐Ÿ’ก newsR Knowledge: Other News Mentions

Bharat Biotech

Indian biotechnology company and vaccine manufacturer
Bharat Biotech on Friday said it has committed to supply over 500 million doses of its COVID-19 vaccine Covaxin to the Centre under the countrywide immunisation..
Credit: IndiaTimes - Published 2 days ago

Not just Bharat Biotech's Covaxin but Zydus Cadila's vaccine for children is also currently under trial in India
Credit: DNA - Published 2 days ago




Covaxin

Vaccine against COVID-19
In view of a probable third wave of the pandemic, vaccination trials on children have been underway in India with Covaxin and Zydus Cadila's ZyCov-D.
Credit: DNA - Published 1 day ago

Related news from verified sources

Hyderabad-based Bharat Biotech's pre-submission meeting has been scheduled on June 23 for evaluation of the World Health Organisation (WHO)'s Emergency Use...
on June 17, 2021 • IndiaTimes

The World Health Organisation (WHO) has accepted Bharat Biotechโ€™s expression of interest (EoI) for the emergency use listing (EUL) of India's first...
on June 17, 2021 • IndiaTimes

You might like